← Leaderboards
David Linn Perkins
Brigham And Women'S Hospital
$5,661,344
Attributed
$10,612,022
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,612,022 · 7
By mechanism
R01$7,527,897 · 4
U01$2,296,559 · 1
R21$411,750 · 1
T32$375,816 · 1
Top collaborators
- Patricia W Finn15 shared
- Maria-Luisa Alegre5 shared
- Stefan Gunther Tullius5 shared
- Justin T Baca2 shared
- Jeffrey R Jacobson1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Patricia W Finn$14,298,228
- Vijay K Kuchroo$71,617,613
- George R Washko$16,445,968
- Reza Abdi$32,829,278
- Eric Garland Sheu$3,405,774
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineResponseImmune ResponseBiologicalInvestigationT-LymphocyteImmunePathway InteractionsMediatingImmunosuppressive AgentsClinically RelevantIn VivoAffectImmunityReceptorBaseLungInflammatoryAntigensPathogenInterleukin-17Animal ModelCellsInsight
Grant awards (28)
University of New Mexico Leading Equity and Diversity in the Medical Scientist Training Program (UNM LEAD MSTP)$248,356
T32 · FY2025 · GM
University of New Mexico Leading Equity and Diversity in the Medical Scientist Training Program (UNM LEAD MSTP)$127,460
T32 · FY2024 · GM
Precision Medicine in Sarcoidosis$912,947
R01 · FY2021 · HL
The microbiota and allograft rejection: novel investigations into the consequences of obesity$403,766
U01 · FY2021 · AI
Precision Medicine in Sarcoidosis$914,660
R01 · FY2020 · HL
The microbiota and allograft rejection: novel investigations into the consequences of obesity$403,766
U01 · FY2020 · AI
Precision Medicine in Sarcoidosis$914,660
R01 · FY2019 · HL
The microbiota and allograft rejection: novel investigations into the consequences of obesity$642,745
U01 · FY2019 · AI
Precision Medicine in Sarcoidosis$680,760
R01 · FY2018 · HL
The microbiota and allograft rejection: novel investigations into the consequences of obesity$403,766
U01 · FY2018 · AI
Precision Medicine in Sarcoidosis$143,095
R01 · FY2018 · HL
The microbiota and allograft rejection: novel investigations into the consequences of obesity$442,516
U01 · FY2017 · AI
Pulmonary Interactions with Innate Immunity$367,367
R01 · FY2013 · AI
Pulmonary Interactions with Innate Immunity$245,059
R01 · FY2012 · AI
Pulmonary Interactions with Innate Immunity$225,990
R01 · FY2012 · AI
Pulmonary Interactions with Innate Immunity$378,564
R01 · FY2011 · AI
Transplantation: Alloimmune Networks$264,995
R01 · FY2011 · AI · contact PI
Pulmonary Interactions with Innate Immunity$86,903
R01 · FY2011 · AI
Pulmonary Interactions with Innate Immunity$382,388
R01 · FY2010 · AI
Transplantation: Alloimmune Networks$267,671
R01 · FY2010 · AI · contact PI
Pulmonary Interactions with Innate Immunity$386,250
R01 · FY2009 · AI
Transplantation: Alloimmune Networks$270,375
R01 · FY2009 · AI · contact PI
Pulmonary Interactions with Innate Immunity$21,778
R01 · FY2009 · AI
Transplantation: Graft Cell Promotion of Rejection$411,750
R21 · FY2004 · AI
CD40 COSTIMULATION AND TRANSPLANTATION$275,441
R01 · FY2003 · AI
CD40 COSTIMULATION AND TRANSPLANTATION$275,364
R01 · FY2002 · AI
CD40 COSTIMULATION AND TRANSPLANTATION$260,610
R01 · FY2001 · AI
CD40 COSTIMULATION AND TRANSPLANTATION$253,020
R01 · FY2000 · AI